Brian Liau

Brian Liau is an Associate Professor of Chemistry and Chemical Biology at Harvard University, affiliated with the Department of Chemistry and Chemical Biology. His research focuses on bioorganic chemical biology and organic chemistry, with an emphasis on developing chemical approaches to study gene regulation and chromatin regulators as therapeutic targets. Liau's work integrates chemistry with biochemistry, cell & molecular biology, and functional genomics to investigate biological mechanisms. He joined the Harvard faculty in 2016 after earning an A.B. in Chemistry & Physics in 2007 and a Ph.D. in Chemistry in 2013 from Harvard, followed by postdoctoral research on cancer epigenetics at Massachusetts General Hospital.

Brian B. Liau is a chemical biologist at Harvard University whose research focuses on Chemical Biology, Genomics, and Cancer Epigenetics. His work explores the molecular mechanisms underlying cancer progression, particularly in gliomas and leukemia, with an emphasis on chromatin remodeling, transcriptional regulation, and drug resistance. Liau's research integrates genomic and chemical approaches to identify therapeutic targets and develop novel strategies for cancer treatment. His studies have uncovered key roles for epigenetic regulators, transcription elongation factors, and drug resistance mutations in oncogenesis. By combining synthetic chemistry with functional genomics, Liau's lab aims to uncover new biological insights and therapeutic opportunities in cancer.